BioMarin Pharmaceutical Inc. Equity-NMS: BMRN

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$67.48
Open :$66.25
Today's high :$66.49
Today's low :$59.99
52W low :$59.99
52W high :$94.85
EPS(TTM): :2.21
Shares O/S :190.78 M
Market cap :11.5 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
BioMarin Pharmaceutical Inc. $60.26 -3.88% 30.53 11.50B

Frequently Asked Questions

What is the share price of BioMarin Pharmaceutical Inc. today?

BioMarin Pharmaceutical Inc. (BMRN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.